4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000192
Chairperson & CEO sold 5,410 shares at an average $578.83 ($3,131,476)
- Chairperson & CEO acquired 5,410 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,410 | $117.76 | $637,082 | 329,853 | I |
| 2026-11-18 | Sale : show line 2 in the form 10b5-1 | −120 | $570.82 | $68,498 | 329,733 | I |
| 2026-11-18 | Sale : show line 3 in the form 10b5-1 | −80 | $571.63 | $45,731 | 329,653 | I |
| 2026-11-18 | Sale : show line 4 in the form 10b5-1 | −140 | $573.40 | $80,276 | 329,513 | I |
| 2026-11-18 | Sale : show line 5 in the form 10b5-1 | −259 | $574.36 | $148,758 | 329,254 | I |
| 2026-11-18 | Sale : show line 6 in the form 10b5-1 | −201 | $575.26 | $115,628 | 329,053 | I |
| 2026-11-18 | Sale : show line 7 in the form 10b5-1 | −440 | $576.65 | $253,727 | 328,613 | I |
| 2026-11-18 | Sale : show line 8 in the form 10b5-1 | −909 | $577.59 | $525,033 | 327,704 | I |
| Open-market sales · 5,410 sh · avg $578.83 · $3,131,476 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-18 | Exercise or conversion : show line 17 in the form 10b5-1 Stock Option | −5,410 | $117.76 | 2027-03-15 | 5,410 | 0 | I |
Loading xslF345X06/primarydocument.xml…